Tianeptine: Potential influences on neuroplasticity and novel pharmacological effects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 915-924

  Uzbay, Tayfun I ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Apoptosis; Neurogenesis; Neuroplasticity; Nociception; Seizure; Tianeptine

Indexed keywords

BROXURIDINE; FLUOXETINE; SEROTONIN; TIANEPTINE;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POSTSYNAPTIC POTENTIAL; REVIEW; SEROTONINERGIC SYSTEM;

ANALGESICS; ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; NEURONAL PLASTICITY; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; THIAZEPINES;

EID: 42949088476     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.007     Document Type: Review

References (88)

1. Alfonso J., Pollevick G.D., Van Der Hart M.G., Flugge G., Fuchs E., and Frasch A.C. Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 19 (2004) 659-666
2. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., and Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 59 (2006) 244-251
3. Ansseau M. The paradox of tianeptine. Eur Psychiatry 8 Suppl. 2 (1993) 89S-93S
4. 1H-NMR spectroscopy studies of the brain. Neurosci Biobehav Rev 13 (1989) 23-31
5. Brand A., Richter-Landsberg C., and Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15 (1993) 289-298
6. Burghardt N.S., Sullivan G.M., McEwen B.S., Gorman J.M., and LeDoux J.E. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55 (2004) 1171-1178
7. Castrén E. Is mood chemistry?. Nat Rev Neurosci 6 (2005) 241-246
8. Ceyhan M., Kayir H., and Uzbay I.T. Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. J Psychiatr Res 39 (2005) 191-196
9. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., and Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75 (2000) 1729-1734
10. Cutler M.G., Rodgers R.J., and Jackson J.E. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions. Pharmacol Biochem Behav 56 (1997) 287-293
11. Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 98 (2001) 12796-12801
12. Czéh B., Welt T., Fischer A.K., Erhardt A., Schmitt W., and Muller M. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 52 (2002) 1057-1065
13. Curzon G., and Datla K.P. Effects of tianeptine on behavioral and neurochemical responses in immobilization stress. Eur Psychiatry 8 Suppl. 2 (1993) 61S-66S
14. Defrance R., Marey C., and Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clin Neuropharmacol 11 Suppl. 2 (1988) 74-82
15. Diamond D.M., Campbell A., Park C.R., and Vouimba R.-M. Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. Eur Neuropsychopharmacol 14 Suppl. 5 (2004) S491-S495
16. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 17 Suppl. 3 (2002) 306-310
17. Duman R.S., Malberg J., Nakagawa S., and D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48 (2000) 732-739
18. Eisch A.J. Adult neurogenesis: implications for psychiatry. Prog Brain Res 138 (2002) 315-342
19. File S.E., and Mabbutt P.S. Effects of tianeptine in animal models of anxiety and on learning and memory. Drug Dev Res 23 (1991) 47-56
20. File S., Andrews N., and Al-Farhan M. Anxiogenic responses of rats on withdrawal from chronic ethanol treatment: effects of tianeptine. Alcohol Alcohol 28 (1993) 281-286
21. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 1 (2000) 310-316
22. Forstermann U., Gorsky L.D., Pollock J.S., Schmidt H.H., Heller M., and Murad F. Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun 168 (1990) 727-732
23. Foy M.R., Stanton M.E., Levine S., and Thompson R.F. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav Neural Biol 48 (1987) 138-149
24. Fuchs E., and Gould E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. Eur J Neurosci 12 (2000) 2211-2214
25. Fuchs E., Czéh B., Michaelis T., de Biurrun G., Watanabe T., and Frahm J. Synaptic plasticity and tianeptine: structural regulation. Eur Psychiatry 17 Suppl. 3 (2002) 311-317
26. Fuchs E., Czéh B., Kole M.H., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14 (2004) S481-S490
27. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
28. Garthwaite J., Garthwaite G., Palmer R.M., and Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172 (1989) 413-416
29. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21 (1999) 46S-51S
30. Gould E., McEwen B.S., Tanapat P., Galea L.A., and Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17 (1997) 2492-2498
31. Goren M.Z., Ari{dotless}ci{dotless}oǧlu-Kartal F., Yurdun T., and Uzbay I.T. Investigation of extracellular l-citrulline concentration in the striatum during alcohol withdrawal in rats. Neurochem Res 26 (2001) 1327-1333
32. Guelfi J.D. Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview. Br J Psychiatrty 160 Suppl. 15 (1992) 72-75
33. Guelfi J.D., Pichot P., and Dreyfus J.F. Efficacy of tianeptine in anxious-depressed patients. Results of a controlled multicentre trial versus amitriptyline. Neuropsychobiology 1 (1989) 41-48
34. Heasley L.E., Storey B., Fanger G.R., Butterfield L., Zamarripa J., Blumberg D., et al. GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases. Mol Cell Biol 16 (1996) 648-656
35. Heine V.M., Maslam S., Zareno J., Joëls M., and Lucassen P.J. Supressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur J Neurosci 19 (2004) 131-144
36. Hollister L.E. Treatment of depression with drugs. Ann Intern Med 89 (1978) 78-84
37. Jezova D. Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications. Endocrine 28 (2005) 287-294
38. Kanner A., and Nieto J.C.R. Depressive disorders in epilepsy. Neurology 53 Suppl. 2 (1999) 26-32
39. Kato G., and Weitsch A.F. Neurochemical profile of tianeptine, a new antidepressant drug. Clin Neuropharmacol 11 Suppl. 2 (1988) S43-S50
40. Kim J.J., and Diamond D.M. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3 (2002) 453-462
41. Koe B.K., and Weissman A. p-Chlorophenylalanine: a specific depletory of brain serotonin. J Pharmacol Exp Ther 154 (1966) 499-516
42. Kole M.H., Swan L., and Fuchs E. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 16 (2002) 807-816
43. Kühn K.U., Quednow B.B., Thiel M., Falkai P., Maier W., and Elger C. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 4 (2003) 674-679
44. Lucassen P.J., Fuchs E., and Czéh B. Antidepressant treatment with tianeptine reduces apopitosis in hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55 (2004) 789-796
45. Madsen T.M., Trechow A., Bengzon J., Bolwig T.G., Lindvall O., and Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47 (2000) 1043-1049
46. Magarinos A.M., Deslandes A., and McEwen B.S. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 371 (1999) 113-122
47. Malagié I., Deslandes A., and Gardier A.M. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403 (2000) 55-65
48. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
49. McAllister A.K., Katz L.C., and Lo D.C. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22 (1999) 295-318
50. McEwen B.S., and Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 14 Suppl. 5 (2004) S497-S502
51. McEwen B.S., Magarinos A.M., and Reagan L.P. Structural plasticity and tianeptine: cellular and molecular targets. Eur Psychiatry 17 Suppl. 3 (2002) 318-330
52. Mennini T., Mocaër E., and Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn-Schmiedebergs Arch Pharmacol 336 (1987) 478-482
53. Mocaër E., Rettori M.C., and Kamoun A. Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin Neuropharmacol 11 Suppl 2 (1988) S32-S42
54. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
55. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 59 (2005) 1435-1440
56. Mukobata S., Hibino T., Sugiyama A., Urano Y., Inatomi A., Kanai Y., et al. M6a acts as a nerve growth factor-gated Ca(2+) channel in neuronal differentiation. Biochem Biophys Res Commun 297 (2002) 722-728
57. Muniz P.S., and Nardi A.E. Refractory pain-depression syndrome treated with tianeptine: a case report. Aust N Z J Psychiatry 38 (2004) 176
58. Myers M.P., Murphy M.B., and Landreth G. The dual-specificity CLK kinase induces neuronal differentiation of PC12 cells. Mol Cell Biol 14 (1994) 6954-6961
59. Paul I.A., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003 (2003) 250-272
60. Pham K., Nacher J., Hof P.R., and McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 17 (2003) 879-886
61. Pineyro G., Deveault L., Blier P., Dennis T., and de Montigny C. Effects of acute and prolonged administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 351 (1995) 111-118
62. Pineyro G., Deveault L., de Montigny C., and Blier P. Effects of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn-Schmiedebergs Arch Pharmacol 351 (1995) 119-125
63. Pisani F., Spina E., and Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40 Suppl 10 (1999) S48-S56
64. Plaisant F., Dommergues M.A., Spedding M., Cecchelli R., Brillaut J., Kato G., et al. Neuroprotective properties of tianeptine: interactions with cytokines. Neuropharmacology 44 (2003) 801-809
65. Prediger R.D., Batista L.C., and Takahashi R.D. Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice. Eur J Pharmacol 499 (2004) 147-154
66. Prediger R.D., da Siva G.E., Batista L.C., Bittencourt A.L., and Takahashi R.N. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. Neuropsychopharmacology 31 (2006) 2210-2220
67. Reagan L.P., Rosell D.R., Wood G.E., Spedding M., Munoz C., Rothstein J., et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci U S A 101 (2004) 2179-2184
68. Reagan L.P., Hendry R.M., Reznikov L.R., Piroli G.G., Wood G.E., McEwen B.S., et al. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdale. Eur J Pharmacol 565 (2007) 68-75
69. Robertson M.M. Depression in patients with epilepsy: an overview and clinical study. In: Trimble M.R. (Ed). The Psychopharmacology of epilepsy (1985), John Wiley, Chichester 65
70. Rocher C., Spedding M., Munoz C., and Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 14 (2004) 224-229
71. Sala M., Perez J., Soloff P., di Nemi S.U., Caverzasi E., Soares J.C., et al. Stress and hippocampus abnormalities in psychiatric disorders. Eur Neuropsychopharmacol 14 (2004) 393-405
72. Sanchez-Mateo C.C., Darias V., Albertos L.M., and Exposito-Orta M.A. Psychopharmacological effects of tianeptine analogous hetero [2,1] benzothiazepine derivatives. Arzneimit-Forsch Drug Res 53 (2003) 12-20
73. Scott B.W., Wojtowicz J.M., and Burnham W.M. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol 165 (2000) 231-236
74. Shakesby A.C., Anwyl R., and Rowan M.J. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 22 (2002) 3638-3644
75. Snyder S.H., and Bredt D.S. Biological roles of nitric oxide. Sci Am (1992) 68-77 [May]
76. Urenjak J., Willliams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993) 981-989
77. Uzbay I.T., and Oglesby M.W. Nitric oxide and substance dependence. Neurosci Biobehav Rev 25 (2001) 43-52
78. Uzbay I.T., Cinar M.G., Aytemir M., and Tuglular I. Analgesic effect of tianeptine in mice. Life Sci 64 (1999) 1313-1319
79. Uzbay I.T., Celik T., Aydin A., Kayir H., Tokgoz S., and Bilgi C. Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3′,5′-monophosphate (cGMP) levels in the rat brain. Drug Alcohol Depend 74 (2004) 55-59
80. Uzbay I.T., Kayir H., Çelik T., and Yuksel N. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats. Prog Neuropsychopaharmacol Biol Psychiatry 30 (2006) 478-485
81. Uzbay T.I., Kayir H., and Ceyhan M. Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors. Neuropsychopharmacology 32 (2007) 412-416
82. van der Hart M.G., Czeh B., de Biurrun G., Michaelis T., Watanabe T., Natt O., et al. Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry 7 (2002) 933-941
83. Vouimba R.M., Munoz C., and Diamond D.M. Influence of the antidepressant tianeptine and stress on the expression of synaptic plasticity in the hippocampus and amygdala. Soc Neurosci (2003) 376.6
84. Vouimba R.M., Munoz C., and Diamond D.M. Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 9 (2006) 29-40
85. Wagstaff A.J., Ormrod D., and Spencer C.M. Tianeptine: a review of its use in depressive disorders. CNS Drugs 15 (2001) 231-259
86. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res 959 (2003) 128-134
87. Wilde M.I., and Benfield P. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49 (1995) 411-439
88. Zethof T.J., Van der Heyden J.A., Tolboom J.T., and Olivier B. Stress-induced hyperthermia as a putative anxiety model. Eur J Pharmacol 294 (1995) 125-135